CLINICAL_TRIALS
trial_result
· 2016-11-30
Clinical Trial Update: Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse [Phase 1]
Summary
Phase 1 trial evaluating guanfacine for reducing stress-induced cocaine and alcohol craving and relapse; the study has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Cocaine Dependent, Alcohol Dependent | Phase 1 | Status: COMPLETED